IL124522A0 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
IL124522A0
IL124522A0 IL12452296A IL12452296A IL124522A0 IL 124522 A0 IL124522 A0 IL 124522A0 IL 12452296 A IL12452296 A IL 12452296A IL 12452296 A IL12452296 A IL 12452296A IL 124522 A0 IL124522 A0 IL 124522A0
Authority
IL
Israel
Prior art keywords
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
IL12452296A
Other languages
English (en)
Original Assignee
Smithkline Beecham Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI952461 external-priority patent/IT1276170B1/it
Priority claimed from ITMI961689 external-priority patent/IT1307331B1/it
Application filed by Smithkline Beecham Spa filed Critical Smithkline Beecham Spa
Publication of IL124522A0 publication Critical patent/IL124522A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12452296A 1995-11-24 1996-11-22 Quinoline derivatives IL124522A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI952461 IT1276170B1 (it) 1995-11-24 1995-11-24 Derivati chinolinici
ITMI961689 IT1307331B1 (it) 1996-08-02 1996-08-02 Derivati chinolinici
PCT/EP1996/005203 WO1997021680A1 (en) 1995-11-24 1996-11-22 Quinoline derivatives

Publications (1)

Publication Number Publication Date
IL124522A0 true IL124522A0 (en) 1998-12-06

Family

ID=26331326

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12452296A IL124522A0 (en) 1995-11-24 1996-11-22 Quinoline derivatives

Country Status (26)

Country Link
US (1) US6277862B1 (OSRAM)
EP (1) EP0876347B1 (OSRAM)
JP (1) JP2000501104A (OSRAM)
KR (1) KR19990071597A (OSRAM)
CN (1) CN1207730A (OSRAM)
AP (1) AP9801237A0 (OSRAM)
AR (1) AR004972A1 (OSRAM)
AT (1) ATE289994T1 (OSRAM)
BG (1) BG102558A (OSRAM)
BR (1) BR9611820A (OSRAM)
CA (1) CA2238298A1 (OSRAM)
CZ (1) CZ157998A3 (OSRAM)
DE (1) DE69634416T2 (OSRAM)
EA (1) EA002124B1 (OSRAM)
ES (1) ES2236757T3 (OSRAM)
IL (1) IL124522A0 (OSRAM)
MX (1) MX9804107A (OSRAM)
NO (1) NO311212B1 (OSRAM)
NZ (1) NZ323387A (OSRAM)
OA (1) OA11010A (OSRAM)
PL (1) PL326967A1 (OSRAM)
SK (1) SK66798A3 (OSRAM)
TR (1) TR199800924T2 (OSRAM)
TW (1) TW353066B (OSRAM)
UY (1) UY24733A1 (OSRAM)
WO (1) WO1997021680A1 (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007751A1 (en) * 1991-10-18 1993-04-29 Monsanto Company Fungicides for the control of take-all disease of plants
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
GB9825554D0 (en) * 1998-11-20 1999-01-13 Smithkline Beecham Spa Novel Compounds
US7037922B1 (en) * 2000-03-10 2006-05-02 Neurogen Corporation Aryl fused 2,4-disubstituted pyridines: NK3 receptor ligands
AU4038600A (en) 1999-03-29 2000-10-16 Neurogen Corporation 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
WO2000064877A1 (en) 1999-04-26 2000-11-02 Neurogen Corporation 2-aminoquinolinecarboxamides: neurokinin receptor ligands
WO2002083663A1 (en) * 2001-04-11 2002-10-24 Glaxosmithkline S.P.A. Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
AU2002259147A1 (en) * 2001-05-08 2002-11-18 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
ATE365174T1 (de) 2003-01-28 2007-07-15 Microbia Inc Zusammensetzungen zur behandlung von gastrointestinalen störungen
GB0303086D0 (en) 2003-02-11 2003-03-19 Merck Sharp & Dohme New compounds
GB0419192D0 (en) 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
BRPI0517567A (pt) * 2004-11-09 2008-06-17 Smithkline Beecham Corp composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo, composição farmacêutica, usos de um composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo e de uma composição farmacêutica, e, processo para preparar um composto
GB0425077D0 (en) * 2004-11-12 2004-12-15 Smithkline Beecham Corp Novel compounds
GB0515580D0 (en) 2005-07-29 2005-09-07 Merck Sharp & Dohme Therapeutic compounds
JP2009504641A (ja) * 2005-08-11 2009-02-05 アストラゼネカ・アクチエボラーグ Ｎｋ−３受容体の調節剤としてのアルキルピリジルキノリン
AR057130A1 (es) 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
TW201018662A (en) * 2005-12-12 2010-05-16 Astrazeneca Ab Alkylsulphonamide quinolines
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
BRPI0817721A2 (pt) * 2007-09-28 2015-03-31 Glaxosmithkline Llc Composto, composição farmacêutica, método de tratamento, e, processo para preparação de um composto
BRPI0817445A2 (pt) * 2007-09-28 2015-10-27 Glaxosmithkline Llc composto, composição farmacêutica, método de tratamento, e, processo para preparar um composto
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP2384318B1 (en) 2008-12-31 2017-11-15 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
HK1211469A1 (en) 2012-08-21 2016-05-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
NZ752535A (en) 2013-04-12 2022-08-26 Ardelyx Inc Nhe3-binding compounds and methods for inhibiting phosphate transport
WO2014170648A1 (en) 2013-04-19 2014-10-23 Astrazeneca Ab A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos)
EP4424697A3 (en) 2013-06-05 2024-12-25 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2017072629A1 (en) 2015-10-29 2017-05-04 Cadila Healthcare Limited Pharmaceutical combination of nk3 receptor antagonist and biguanides
WO2018129552A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
WO2018129557A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Inhibitors of nhe-mediated antiport

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2538388B1 (fr) * 1982-12-24 1985-06-21 Pharmuka Lab Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments
JPS6399057A (ja) * 1986-06-27 1988-04-30 Nippon Shinyaku Co Ltd グリシン誘導体
DE69533408T2 (de) * 1994-05-27 2005-09-08 Glaxosmithkline S.P.A. Chinolinderivate als Tachykinin NK3 Rezeptor Antagonisten
IT1270615B (it) * 1994-07-14 1997-05-07 Smithkline Beecham Farma Uso di derivati di chinolina

Also Published As

Publication number Publication date
NO982331D0 (no) 1998-05-22
UY24733A1 (es) 2001-08-27
NO982331L (no) 1998-07-22
CZ157998A3 (cs) 1998-12-16
DE69634416D1 (de) 2005-04-07
AR004972A1 (es) 1999-04-07
WO1997021680A1 (en) 1997-06-19
US6277862B1 (en) 2001-08-21
ES2236757T3 (es) 2005-07-16
ATE289994T1 (de) 2005-03-15
SK66798A3 (en) 1999-01-11
EA002124B1 (ru) 2001-12-24
KR19990071597A (ko) 1999-09-27
EA199800477A1 (ru) 1998-12-24
DE69634416T2 (de) 2005-12-29
PL326967A1 (en) 1998-11-09
NO311212B1 (no) 2001-10-29
AP9801237A0 (en) 1998-06-30
MX9804107A (es) 1998-09-30
BG102558A (bg) 1999-03-31
EP0876347B1 (en) 2005-03-02
TR199800924T2 (xx) 1998-08-21
OA11010A (en) 2003-03-06
TW353066B (en) 1999-02-21
JP2000501104A (ja) 2000-02-02
CA2238298A1 (en) 1997-06-19
BR9611820A (pt) 1999-07-13
EP0876347A1 (en) 1998-11-11
NZ323387A (en) 2000-02-28
CN1207730A (zh) 1999-02-10

Similar Documents

Publication Publication Date Title
IL124522A0 (en) Quinoline derivatives
IL113844A0 (en) Quinoline derivatives
NZ305444A (en) 4-anilino-7-alkoxy-quinazoline derivatives
IL152383A0 (en) 5-amino-3-cyano-4-ethylsulfinyl-1- phenyl-pyrazole derivatives
IL135376A0 (en) Hydroxyalkyl-phenyl derivatives
GB2306473A8 (en) Glucoxide derivatives
SG64953A1 (en) Purin-6-one derivatives
HU9600876D0 (en) Benzonitril- and -fluoride derivatives
ZA977326B (en) Tetrahydroquinoline derivatives
ZA969812B (en) Novel quinoline derivatives.
HUP9600107A2 (en) 9-substituted-2-(2-n-alkoxy-phenyl)-purin-6-one derivatives
NZ332395A (en) Benzonthiazole derivatives
SI0758644T1 (en) Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
HUP9900672A3 (en) Pyrroloazepine derivatives
SG60005A1 (en) 1-Fluorocyclohexene-difluorophenyl derivatives
IL123621A0 (en) Diarylalkenylamine derivatives
GB9404378D0 (en) Quinoline derivatives
GR3035577T3 (en) Benzisothiazolyl-substituted aminomethylchroman derivatives
IL117858A0 (en) 4-Indolypiperazinyl derivatives
ZA954269B (en) Quinoline derivatives
GR3036572T3 (en) 4-amino-benzoylguanidine derivatives
GB9402275D0 (en) Quinoline derivatives
GB9413150D0 (en) Quinoline derivatives
HU9602324D0 (en) Piperidinyl-methyl-oxazolidinon derivatives
EP0754668A3 (de) Fluorbenzylether-Derivate